基于环糊精的靶向药物传递系统

癌症等恶性增殖疾病的靶向治疗有赖于靶向药物传递系统（targeted drug delivery system,TDDS）的开发。环糊精具有低毒、易修饰等优良性质,并可通过与药物分子形成包合物而提高药物的溶解性、稳定性、安全性和生物利用度等,因而具有成为优秀药物载体的潜力。环糊精不仅可以以其本身或修饰环糊精的形式充当载体,还可通过聚轮烷、阳离子聚合物或纳米粒等形式构建有效的药物载体。肿瘤或人体某些病变部位的细胞表面存在过度表达的生物受体如叶酸受体、去唾液酸糖蛋白受体、透明质酸受体、转铁蛋白受体和整合素受体等,可以与其相应的配体产生特异性识别。用适当的化学方法将配体分子如叶酸、单糖或寡糖、透明质酸、转铁蛋白及RGD肽等键接在基于环糊精的载体上,可形成具有靶向性质的药物载体,进而与药物分子一起构筑靶向药物传递系统。这种药物传递系统不仅针对于化学治疗药物,在核酸传递中也得到了丰富的应用。本文综述了基于环糊精的靶向药物传递系统的靶向机理及最新研究进展,并对其发展前景作了展望。     

Tuning Macromolecular Structures of Synthetic Vectors for Gene Therapy

Summary: The synthesis of triblocks poly(2-methyl-2-oxazoline-b-tetrahydrofurane-b-2-methyl-2-oxazoline) has been developed. It was shown that the technique of polymerization of the second block from the living species created on the two chain ends of poly(THF) is successful but makes the control of the size of the poly(THF) block difficult due a fast depolymerization upon the introduction of the second monomer. A purification technique was used to get rid of the possible homopoly(2-methyl-2-oxazoline) formed. Various analytical techniques were used to characterize the behavior of the triblock and more particularly in the presence of DNA. Electrophoresis on agarose gels and neutron scattering, demonstrated that the neutral triblock does not appreciably interact with DNA. It was also shown that the triblock for which approximately half (47%) of the methyloxazoline units were transformed into ethylenimine units by hydrolysis gives only loose interactions with DNA. This result is assigned to the fact that charge density plays a major role in the interactions of positive polyelectrolytes with the negatively charged DNA. The triblock was shown being able to interact with bilayer lipid membranes mimicking cell membranes. The efficiency of the hydrolysed triblock was much higher, while the size of holes created in the membranes is not large enough to give passage to DNA.     

Comparative Analysis of the Antitumor Activity of Cis- and Trans-Resveratrol in Human Cancer Cells with Different p53 Status

Resveratrol, a natural plant phytoalexin, is produced in response to fungal infection or− UV irradiation. It exists as an isomeric pair with cis- and trans-conformation. Whereas multiple physiological effects of the trans-form, including a pronounced anti-tumoral activity, are nowadays elucidated, much less knowledge exists concerning the cis-isomer. In our work, we analyzed the antiproliferative and cytotoxic properties of cis-resveratrol in four different human tumor entities in direct comparison to trans-resveratrol. We used human cell lines as tumor models for hepatocellular carcinoma (HCC; HepG2, Hep3B), colon carcinoma (HCT-116, HCT-116/p53^(−/−)), pancreatic carcinoma (Capan-2, MiaPaCa-2), and renal cell carcinoma (A498, SN12C). Increased cytotoxicity in all investigated tumor cells was observed for the trans-isomer. To verify possible effects of the tumor suppressor p53 on resveratrol-induced cell death, we used wild type and p53-deleted or -mutated cell lines for every tested tumor entity. Applying viability and cytotoxicity assays, we demonstrated a differential, dose-dependent sensitivity towards cis- or trans-resveratrol among the respective tumor types.     

Infection Microenvironment-Sensitive Photothermal Nanotherapeutic Platform to Inhibit Methicillin-Resistant Staphylococcus aureus Infection

Methicillin-resistant Staphylococcus aureus (MRSA) can induce multiple inflammations. The biofilm formed by MRSA is resistant to a variety of antibiotics and is extremely difficult to cure, which seriously threatens human health. Herein, a nanoparticle encapsulating berberine with polypyrrole core and pH-sensitive shell to provide chemo-photothermal dual therapy for MRSA infection is reported. By integrating photothermal agent polypyrrole, berberine, acid-degradable crosslinker, and acid-induced charge reversal polymer, the nanoparticle exhibited highly efficient MRSA infection treatment. In normal uninfected areas and bloodstream, nanoparticles showed negatively charged, demonstrating high biocompatibility and excellent hemocompatibility. However, once arriving at the MRSA infection site, the nanoparticle can penetrate and accumulate in the biofilm within 2 h. Simultaneously, berberine can be released into biofilm rapidly. Under the combined effect of photothermal response and berberine inhibition, 88.7% of the biofilm is removed at 1000 µg mL⁻¹. Moreover, the nanoparticles have an excellent inhibitory effect on biofilm formation, the biofilm inhibition capacity can reach up to 90.3%. Taken together, this pH-tunable nanoparticle can be employed as a new generation treatment strategy to fight against the fast-growing MRSA infection.     

Extracorporeal cardiac shock wave therapy for ischemic heart disease

Prognosis of severe ischemic heart disease with no indication of percutaneous coronary intervention or coronary artery bypass grafting still remains poor. Extracorporeal shock wave therapy was introduced for medical therapy more than 20 years ago to break up kidney stones. We have demonstrated that extracorporeal cardiac shock wave therapy at a low level of ~10% of energy density that used for urinary lithotripsy treatment, effectively induces coronary angiogenesis and improves myocardial ischemia in a porcine model of chronic myocardial ischemia in vivo. On the basis of the promising results in animal studies, we have recently developed a new, non-invasive angiogenic therapy with low-energy shock waves for ischemic heart disease. Our extracorporeal cardiac shock wave therapy improved symptoms and myocardial ischemia in patients with severe coronary artery disease. These beneficial effects of the shock wave therapy persisted for at least 12 months. Importantly, no procedural complications or adverse effects were noted. These results indicate that our extracorporeal cardiac shock wave therapy is an effective and non-invasive treatment for ischemic heart disease. To further confirm the usefulness and safety of our SW therapy, we are currently conducting the second clinical trial in a randomized and placebo-controlled manner.      

Numerical simulation of solid tumor angiogenesis with Endostatin treatment： a combined analysis of inhibiting effect of anti-angiogenic factor and micro mechanical environment of extracellular matrix

To investigate the influence of anti-angiogenesis drug Endostatin on solid tumor angiogenesis, a mathematical model of tumor angiogenesis was developed with combined influences of local extra-cellular matrix mechanical environment, and the inhibiting effects of Angiostatin and Endostatin. Simulation results show that Angiostatin and Endostatin can effectively inhibit the process of tumor angiogenesis, and decrease the number of blood vessels in the tumor. The present model could be used as a valid theoretical method in the investigation of anti-angiogenic therapy of tumors.     

沙疗对骨关节炎兔子股骨骨质影响的对比研究

目的:试验研究维医沙疗对骨关节炎动物模型骨质层转移的影响.方法:采用CT扫描的手段分别四次(建立实验对象OA模型前后各一次、进沙疗第14天和第28天各一次)采集两个实验对象股骨数据.将数据导入MIMICS软件分离实验对象股骨,根据CT值范围不同把股骨分为六个骨质层并读取各层体积.分析了各骨质层的体积在股骨总骨量中所占比例的变化和股骨平均CT值的变化.结果:分析四次CT数据的变化,发现沙疗对象股骨总骨量增长,而对照对象之下降.与此同时沙疗对象股骨平均CT值上升,相比之下对照对象平均CT值下降.结论:沙疗对关节炎对象有促进骨代谢作用,使骨质从低CT值的骨质层转移至高CT值骨质层.     

介导GAD基因的人泡沫病毒载体的构建及其应用

构建了两种新的重组人泡沫病毒载体pGPSNI—hGAD67和pGPSNI—hGAD65，分别携带人符氨酸脱羧酶（GAD）的两种同工酶GAD65和GAD67基因，并研究其在帕金森病（PD）模刭鼠丘脑底核中的表达及对帕金森病的治疗作用．RT—PCR结果表明，人泡沫病毒载体成功地介导了GAD65基因和GAD67基因在PD模型鼠丘脑底核中有效表达．动物行为检测表明，GAD65基因导入组PD模型鼠行为与对照组相比得到明显的改善（n=12，由〈0．01）．     

抑制性消减杂交方法的建立

为建立研究基因表达差异的抑制性消减杂交（SSH）方法，以未加诱导剂处理的结肠癌LoVo细胞提取的mRNA为模板合成的cDNA作为驱赶子（driver)，联合使用10.0μmol/LATRA和0.1μmol/L1,25-(OH)2D3诱导2d的LoVo细胞提取的mRNA为模板合成的cDNA作为测试子（tester)进行SSH实验，结果为：消减产物与未消减样品（对照）在琼脂糖凝胶电泳图谱上明显不同，前者可见一些扩增条带，其大小范围在100-1000bp之间，本实验说明SSH方法对于识别差异表达的基因具有高效性。     

兔VX2移植肝癌及隔离灌注模型建立方法探究

应用开腹瘤块包埋法建立了兔移植肝癌模型,探讨了改良动脉插管技术及提高隔离灌注模型建立的成功率.采用的方法是将实验兔建立移植肝癌模型10d后,按动脉插管方法随机分为3组：A组为直视下儿科静脉留置针插管;B组为显微镜下儿科静脉留置针插管;C组为直视下硬膜外麻醉导管插管.建模成功后经肝动脉灌注奥沙利铂,隔离灌注模型建立前测量肿瘤生长大小,常规病理观察肿瘤,比较插管成功率.研究结果表明：肿瘤生长良好,应用儿科静脉留置针插管成功率明显高于硬膜外麻醉导管,显微镜下插管较直视下无统计学意义,奥沙利铂浓度外周静脉显著低于流出道.由此认为采用儿科静脉留置针插管操作简单,成功率高,建立隔离灌注模型外周血药物泄漏少,阻断较完全,是一种实用的隔离灌注建立方法.